Mechanical support with venoarterial extracorporeal membrane oxygenation (ECMO-VA): Short-term and long-term prognosis after a successful weaning

2017 ◽  
Vol 41 (9) ◽  
pp. 513-522
Author(s):  
R. García-Gigorro ◽  
E. Renes-Carreño ◽  
J.L. Pérez-Vela ◽  
H. Marín-Mateos ◽  
J. Gutiérrez ◽  
...  
Perfusion ◽  
2021 ◽  
pp. 026765912110493
Author(s):  
Jiayi Chen ◽  
Guangyong Jin ◽  
Ying Zhu ◽  
Wei Hu ◽  
Huadong He ◽  
...  

Purpose: In this article, we aimed to elaborate on perioperative and complication management in treatment of pheochromocytoma crisis with extracorporeal membrane oxygenation (ECMO). Material and methods: We report a case of relatively rare grant paraganglioma-induced pheochromocytoma crisis leading to severe circulatory failure, treated with venoarterial extracorporeal membrane oxygenation (V-A ECMO) as a bridge to curative adrenalectomy. Weaning of ECMO was followed by successful surgical removal of the tumor, and patient survival. However, distal ischemia of the cannulated leg occurred during ECMO operation, which eventually led to amputation. In addition, the patient developed new cerebral infarction and left hemiplegia, half a month after paraganglioma resection. Conclusions: We believe that patients with pheochromocytoma crisis, who cannot maintain blood circulation, are eligible for V-A ECMO treatment. Moreover, care should be taken to prevent thrombosis and individualized and precise blood pressure management targets. Early detection and treatment of thrombosis is imperative to long-term prognosis of patients with ECMO.


2021 ◽  
Vol 36 (3) ◽  
pp. 815-820
Author(s):  
Brian Ayers ◽  
Milica Bjelic ◽  
Neil Kumar ◽  
Katherine Wood ◽  
Bryan Barrus ◽  
...  

2015 ◽  
Vol 30 (5) ◽  
pp. 949-956 ◽  
Author(s):  
Aidan J.C. Burrell ◽  
Vincent A. Pellegrino ◽  
Rory Wolfe ◽  
Wen Kai Wong ◽  
David Jamie Cooper ◽  
...  

2018 ◽  
Vol 155 (2) ◽  
pp. 643-649 ◽  
Author(s):  
Stefan Guth ◽  
Christoph B. Wiedenroth ◽  
Marc Wollenschläger ◽  
Manuel Jonas Richter ◽  
Hossein A. Ghofrani ◽  
...  

2019 ◽  
Vol 13 ◽  
pp. 175346661984894 ◽  
Author(s):  
Soo Jin Na ◽  
Jae-Seung Jung ◽  
Sang-Bum Hong ◽  
Woo Hyun Cho ◽  
Sang-Min Lee ◽  
...  

Background: There are limited data regarding prolonged extracorporeal membrane oxygenation (ECMO) support, despite increase in ECMO use and duration in patients with respiratory failure. The objective of this study was to investigate the outcomes of severe acute respiratory failure patients supported with prolonged ECMO for more than 28 days. Methods: Between January 2012 and December 2015, all consecutive adult patients with severe acute respiratory failure who underwent ECMO for respiratory support at 16 tertiary or university-affiliated hospitals in South Korea were enrolled retrospectively. The patients were divided into two groups: short-term group defined as ECMO for ⩽28 days and long-term group defined as ECMO for more than 28 days. In-hospital and 6-month mortalities were compared between the two groups. Results: A total of 487 patients received ECMO support for acute respiratory failure during the study period, and the median support duration was 8 days (4–20 days). Of these patients, 411 (84.4%) received ECMO support for ⩽28 days (short-term group), and 76 (15.6%) received support for more than 28 days (long-term group). The proportion of acute exacerbation of interstitial lung disease as a cause of respiratory failure was higher in the long-term group than in the short-term group (22.4% versus 7.5%, p < 0.001), and the duration of mechanical ventilation before ECMO was longer (4 days versus 1 day, p < 0.001). The hospital mortality rate (60.8% versus 69.7%, p = 0.141) and the 6-month mortality rate (66.2% versus 74.0%, p = 0.196) were not different between the two groups. ECMO support longer than 28 days was not associated with hospital mortality in univariable and multivariable analyses. Conclusions: Short- and long-term survival rates among patients receiving ECMO support for more than 28 days for severe acute respiratory failure were not worse than those among patients receiving ECMO for 28 days or less.


Sign in / Sign up

Export Citation Format

Share Document